VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $148,000 | -8.1% | 14,975 | +1.4% | 0.56% | +19.0% |
| Q2 2022 | $161,000 | -5.8% | 14,766 | -2.2% | 0.47% | +20.4% |
| Q1 2022 | $171,000 | -43.8% | 15,101 | -22.0% | 0.39% | -19.1% |
| Q4 2021 | $304,000 | -22.4% | 19,359 | -15.4% | 0.49% | +2.3% |
| Q3 2021 | $392,000 | -38.9% | 22,878 | -23.4% | 0.48% | -36.9% |
| Q2 2021 | $642,000 | +33.8% | 29,886 | -6.5% | 0.75% | +42.6% |
| Q1 2021 | $480,000 | +130.8% | 31,959 | +104.4% | 0.53% | +132.6% |
| Q3 2019 | $208,000 | +22.4% | 15,634 | +29.7% | 0.23% | +158.0% |
| Q2 2019 | $170,000 | – | 12,052 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |